Amgen/Cytokinetics heart drug fails in clinical trial
September 3, 2013Research and Development, Sales and Marketing Amgen, Novartis, cytokinetics, omecamtiv mecarbil
A new heart failure drug by Amgen and Cytokinetics has fallen short of its primary endpoint in a Phase II …
GSK’s skin cancer pill Tafinlar gets EMA approval
September 3, 2013Sales and Marketing BMS, GSK, Tafinlar, Yervoy, melanoma
GSK has been granted EMA marketing authorisation for its new metastatic melanoma drug Tafinlar. The EMA’s decision on Tafinlar (dabrafenib) …
Aubagio approved in Europe
September 3, 2013Sales and Marketing Aubagio, Genzyme, Rebif, Sanofi, tecfidera
Sanofi’s once-daily multiple sclerosis pill Aubagio has been authorised by European regulators, paving the way for it to continue its …
Rare disease drugs ‘need separate budget’
September 3, 2013Research and Development, Sales and Marketing NHS, NICE, rare diseases
A group of MPs in the UK are calling for a ring-fenced fund to pay for drugs for rare and …
CordenPharma gets bigger in peptides
September 3, 2013Manufacturing and Production API, CordenPharma, Solvay, peptides
Solvay has reached an agreement to sell its peptide subsidiary Peptisyntha SA to the holding company behind contract manufacturing organisation …
Women in the pharma industry
September 3, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Janssen, Johnson and Johnson, adams, women
In the past pharma has been accused of being too male-orientated in both the laboratory and the boardroom. The idea …
EU green light for ‘new’ Herceptin
September 3, 2013Sales and Marketing EU, Herceptin, Roche, breast cancer
Roche has ticked another approval off Herceptin’s list with the news that the European Commission is allowing a new form …
Proveca appoints former ABPI and AZ president
September 3, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, AZ, Brinsmead, Proveca
The former president of AstraZeneca and the ABPI has been appointed as chairman of pharma firm Proveca. Chris Brinsmead joins …
Edoxaban ‘as effective as warfarin’
September 2, 2013Sales and Marketing DVT, Daiichi Sankyo, VTE, warfarin
Daiichi Sankyo is celebrating after its once-a-day blood thinner edoxaban proved as effective as warfarin in a late-stage trial, although …
Health app data ‘shared’
September 2, 2013Medical Communications, Sales and Marketing health apps, pharma
It has been reported that user information from some of the most popular health and wellbeing apps is being transmitted …
NHS shingles vaccine rolls out for people in their 70s
September 2, 2013Sales and Marketing Merck, NHS, Zostavax, shingles
The NHS will introduce a nationwide shingles vaccination scheme this week aimed at people in their 70s. Merck’s Zostavax will …
Lundbeck appealing against European fine
September 2, 2013Sales and Marketing EMA, Lundbeck, pay for delay
Lundbeck is fighting a ruling by European authorities that could see it fined nearly €100 million over a pay-for-delay deal. …
Breast cancer patients benefit from blogging
September 2, 2013Medical Communications blogging, breast cancer
Breast cancer patients who discuss their personal experiences with the disease online can help both the authors and their audience. …
New media hires at the ABPI




September 2, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ABPI, lisa potter, sean palmer
The ABPI has appointed Lisa Potter as its new head of Media to lead the association’s media function. Starting on …
Self-expiring label wins design award
August 30, 2013Manufacturing and Production, Sales and Marketing label, smart packaging
A pharma label that automatically displays when a product is out of date has won a prestigious Red Dot design …
Eylea receives new European approval
August 30, 2013Research and Development, Sales and Marketing Bayer, CRVO, Eylea, Lucentis, Novartis, wet AMD
ThromboGenics/Novartis’ Jetrea gains NICE ‘yes’
August 30, 2013Alcon, Jetrea, NICE, Novartis, ThromboGenics
Pfizer joins Amazon-like R&D network
August 30, 2013Medical Communications Assay Depot, Pfizer, amazon
Pfizer has become the latest big pharma firm to sign up to Assay Depot, the Amazon-like virtual laboratory. The US …
Forest Labs picks 3 Monkeys Communications for psoriasis brief
August 30, 2013Medical Communications 3 Monkeys Communications, Forest Labs
The 3 Monkeys Communications firm has been chosen to run a new psoriasis brief for Forest Laboratories. The brief is …
Mid Staffs faces criminal case
August 30, 2013Medical Communications, Sales and Marketing Mid Staffs, Monitor, NHS
The fall-out from the Mid Staffordshire NHS Foundation Trust scandal has continued with the news that it is to face …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
